On now! @abhiAsolanki discussing the management of locally recurrent prostate cancer after EBRT #ASTRO20 #pcsm #radonc
Great discussion of patient selection for salvage therapies and potential outcomes.

Bottom line, we need clinical trials!
Now @RobertDen6 discussing Radium-223

Are there biomarkers to follow response? ALP 👇
What about combing AR targeted agents with Ra-223? #ASTRO20 #pcsm
🔑for the #radonc as QB 🏈 when using radium-223 #ASTRO20
Next up @DrSpratticus discussing therapies in mCRPC #ASTRO20 #pcsm
And the transition of these agents in N+ disease and with RT
Novel androgen receptor antagonists that the #radonc should know about👇 #ASTRO20
Tips on the apalutamide rash
And tips on Abi/Pred

Super useful! #ASTRO20
And now case discussions led by @jennamkahn with @RobertDen6 @abhiAsolanki and @DrSpratticus #ASTRO20
Discussion of low volume M1 and local recurrence after brachytherapy. Challenging cases we are encountering with increasing frequency in the clinic.
#ASTRO20
You can follow @DrLesterColl.
Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.

Latest Threads Unrolled: